In Vitro Anti-tumor Immune Response Induced by Dendritic Cells Transfected with Htert Recombinant Adenovirus.
From: Institute of Gastroenterology of PLA, Southwest Hospital, Third Military Medical University, Chongqing 400038, China.
Biochemical and biophysical research communications
- Publish Date: Dec 2006
- ISSN: 0006-291X
- Volume: 351
- Issue: 4
- Pages: 927-34
- Medium: Print
- Language: English
- Citation (JAMA): Chen Ling, Liang Guang-Ping, Tang Xu-Dong, et al. In Vitro Anti-tumor Immune Response Induced by Dendritic Cells Transfected with Htert Recombinant Adenovirus.. Biochem. Biophys. Res. Commun. Dec 2006;351:927-34
Abstract
Transduction with recombinant, replication-defective adenoviral (Ad) vectors encoding a transgene is an efficient method for gene transfer into human dendritic cells (DC). Several studies have demonstrated that epitopes of the human telomerase reverse transcriptase gene (hTERT) can produce CTLs specific for malignant tumors. In this study, we constructed an hTERT recombinant adenovirus (rAd-hTERT) using DNA recombination. We found that human dendritic cells transduced with rAd-hTERT could effectively induce hTERT-specific cytotoxic T lymphocytes (CTLs) in vitro against various tumor cell lines, which were hTERT-positive and HLA-A2 matched. We also found that these hTERT-specific CTLs could not lyse autologous lymphocytes with low telomerase activity. Further studies revealed that rAd-hTERT transduced DCs could increase secretion of IFN-gamma by effector cells when they were co-cultured with hTERT-positive and HLA-A2 matched tumor cell lines. These data suggest that an hTERT vaccine can induce anti-tumor immunity against various tumor cells expressing hTERT in a HLA-A2-restricted fashion in vitro. The transduction of DCs with rAd-hTERT offers a great opportunity in cancer immunotherapy.
Mesh Headings (Keywords): Adenoviridae, Animals, Cell Line, Tumor, Cytotoxicity, Immunologic, Dendritic Cells, Genetic Vectors, HLA-A2 Antigen, Humans, Immunotherapy, Adoptive, Interferon Type II, Neoplasms, T-Lymphocytes, Cytotoxic, Telomerase, Transfection
Check for Full Text / PubMed Unique Identifier (PMID): 17097054
This abstract is part of PubMed, a service of the U.S. National Library of Medicine. PubMed includes more than 17 million citations from MEDLINE and other life science journals for biomedical articles. See Copyright and Disclaimers.
Linked medical terms appearing on this page are added by Healia to help readers find more information and are not part of the original PubMed document.
The data herein was last updated on July 8th, 2008 and may not reflect the most current and accurate data available from NLM.